rs4149621

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The variant allele was found at a frequency of 0.152 in 152,214 control chromosomes in the GnomAD database, including 4,861 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.15 ( 4861 hom., cov: 32)

Consequence

Unknown

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.147

Publications

13 publications found
Variant links:

Genome browser will be placed here

ACMG classification

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 12-6342395-T-C is Benign according to our data. Variant chr12-6342395-T-C is described in ClinVar as Benign. ClinVar VariationId is 669759.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.464 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt

Frequencies

GnomAD3 genomes
AF:
0.152
AC:
23045
AN:
152096
Hom.:
4849
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.470
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.122
Gnomad ASJ
AF:
0.0392
Gnomad EAS
AF:
0.0891
Gnomad SAS
AF:
0.0381
Gnomad FIN
AF:
0.00311
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.00906
Gnomad OTH
AF:
0.128
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.152
AC:
23098
AN:
152214
Hom.:
4861
Cov.:
32
AF XY:
0.150
AC XY:
11151
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.470
AC:
19496
AN:
41492
American (AMR)
AF:
0.122
AC:
1858
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0392
AC:
136
AN:
3472
East Asian (EAS)
AF:
0.0893
AC:
462
AN:
5176
South Asian (SAS)
AF:
0.0377
AC:
182
AN:
4826
European-Finnish (FIN)
AF:
0.00311
AC:
33
AN:
10616
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.00903
AC:
614
AN:
68020
Other (OTH)
AF:
0.128
AC:
271
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
698
1395
2093
2790
3488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0556
Hom.:
1292
Bravo
AF:
0.174
Asia WGS
AF:
0.0910
AC:
317
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
4.9
DANN
Benign
0.35
PhyloP100
0.15
PromoterAI
0.0031
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4149621; hg19: chr12-6451561; API